BACE1 and Alzheimer disease: Besides, Pietro et al.’s (2017) study of conformational ensemble and binding mode analysis of some multisite inhibitors using MD and docking method [36], studies that explore multisite targeting of BACE1 towards drug design for AD are still scarce.